Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Miramar Labs
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
baseline gravimetric measurement of spontaneous resting sweat production of at least 50 mg/5 min at room temperature in each axilla
poor quality-of-life rating on the Hyperhidrosis Disease Severity Scale
primary focal axillary hyperhidrosis evidenced by at least two of the standard criteria
female subjects of child-bearing potential must not be pregnant or lactating and must agree to not become pregnant during the course of the study including follow-up period
female subjects over 40 must have had a mammogram in the last 2 years
subjects must be willing to comply with study visits and requirements
You may not be if
subject has secondary hyperhidrosis (e.g., endocrinopathy, medications)
subject has active infection
subject is pregnant or lactating
subject has had prior surgery for axillary hyperhidrosis
subject has had axillary injections of botulinum toxin A in the last year
subject has used prescription antiperspirants in the last 14 days or plans to use them during the study period
subject has used oral anticholinergics in the last 4 weeks
subject is a prisoner or under incarceration
subject is participating in a another clinical trial (or has in the last 30 days)
subject has history of cancer (some exceptions)
subject has a pacemaker or other electronic implant
subject requires supplemental oxygen
Clareo Health | Efficacy and Safety of the DTS-G2 System in Patients With Axillary Hyperhidrosis
